🔴 Intravenous Infusions is trading 3.28% down; no confirmed catalyst identified

Intravenous Infusions is trading at GHS 0.59, down 3.28% on October 21, 2026, with no confirmed catalyst identified.

• No verified company-specific announcement explaining the decline has been identified. The company’s listed October 23 AGM is upcoming, with no evidence connecting it to the move.
• The available healthcare-sector trend is positive and does not explain the downward move.